Halitosis Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting halitosis clinical trials across 6 countries. Studies span Not Applicable, Phase 3, Phase 1, Phase 2. Top locations include Baghdad, Bab Al-Moadham, Iraq, Baghdad, Iraq, Bauru, São Paulo, Brazil. Updated daily from ClinicalTrials.gov.


Halitosis Trials at a Glance

7 actively recruiting trials for halitosis are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Baghdad, Baghdad, and Bauru. Lead sponsors running halitosis studies include Al-Mustansiriyah University, Sanford Health, and Universitaire Ziekenhuizen KU Leuven.

Browse halitosis trials by phase

Treatments under study

About Halitosis Clinical Trials

Looking for clinical trials for Halitosis? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Halitosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Halitosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabetes Mellitus

Type 2 DiabetesHalitosisPeriodontitis
University of Sao Paulo32 enrolled1 locationNCT07463859
Recruiting
Not Applicable

The Additional Effect of Tongue Scraping on Halitosis Parameters in Initial Periodontal Therapy

HalitosisPeriodontitisTongue Condition
Universitaire Ziekenhuizen KU Leuven39 enrolled1 locationNCT06091228
Recruiting
Not Applicable

Evaluation of the Stability of Sulfur Volatile Compounds From Exhaled Air for Halitosis Diagnosis

Halitosis
University Hospital, Strasbourg, France100 enrolled1 locationNCT06483646
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Multiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2Rare Disorders+337 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting
Phase 2Phase 3

Role of Kefir Mouth Wash in Oral Health Status Amelioration

Plaque-induced gingivitisHalitosisOral Disease
Al-Mustansiriyah University60 enrolled1 locationNCT06900881
Recruiting
Phase 1

Comparative Study Between Photodynamic Therapy with LED Associated with Probiotics in the Treatment of Halitosis

Halitosis
University of Nove de Julho92 enrolled1 locationNCT06583720
Recruiting
Phase 3

Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.

HalitosisPeridontal DiseaseBleeding Gum+2 more
Al-Mustansiriyah University54 enrolled1 locationNCT06882564